Chapters:
0:00 Novel Cas enzymes help overcome CRISPR challenges
11:37 New pipeline of therapies will go after novel targets
14:52 How does the new platform open up possibilities for new diagnostics?
21:05 What risks do you think about?
26:47 What are the company’s two-year goals?
31:07 On the possibilities
CRISPR technology is enabling a new generation …
Share this post
![](https://substackcdn.com/image/fetch/w_120,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F83fbc432-b34f-411f-baf8-40589fb4ec71_430x477.jpeg)
Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences
www.mendelspod.com
28
Share this post
![](https://substackcdn.com/image/fetch/w_120,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F83fbc432-b34f-411f-baf8-40589fb4ec71_430x477.jpeg)
Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences
www.mendelspod.com
1×
Preview
0:00
-6:06
Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences
Sep 05, 2023
∙ Paid
Mendelspod Podcast
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.Listen on
Substack App
RSS Feed
Recent Episodes